APO Research
Talk to an analyst

APO RESEARCH · REPORT

G-protein Coupled Receptor

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global G-protein Coupled Receptor Market Outlook and Growth Opportunities 2026

26 December 2025199 pages

Choose your research edition.

Industry ResearchG-protein Coupled Receptor Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal G-protein Coupled Receptor Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal G-protein Coupled Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal G-protein Coupled Receptor Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal G-protein Coupled Receptor Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global G-protein Coupled Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for G-protein Coupled Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for G-protein Coupled Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for G-protein Coupled Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the G-protein Coupled Receptor market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the G-protein Coupled Receptor market include Abcam plc, Becton, Dickinson, Cisbio Bioassays, DiscoveRx Corporation, EMD Millipore, Enzo Life Sciences, Inc., HD Biosciences Co. Ltd., PerkinElmer, Inc. and Promega Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global G-protein Coupled Receptor market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of G-protein Coupled Receptor and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents G-protein Coupled Receptor revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global G-protein Coupled Receptor market.

G-protein Coupled Receptor Segment by Company

Abcam plc

Becton, Dickinson

Cisbio Bioassays

DiscoveRx Corporation

EMD Millipore

Enzo Life Sciences, Inc.

HD Biosciences Co. Ltd.

PerkinElmer, Inc.

Promega Corporation

Qiagen

AbbVie

Thermo Fisher Scientific, Inc.

Abbott

G-protein Coupled Receptor Segment by Type

cAMP Assays

cGMP Assays

GTPγS Binding Assays

Reporter Gene Assays

Calcium Level Detection Assays

Receptor Internalization Assays

G-protein Coupled Receptor Segment by Application

Oncology

Central Nervous System

Cardiovascular System

Reproductive System

Immune System

Respiratory System

Others

G-protein Coupled Receptor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global G-protein Coupled Receptor status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the G-protein Coupled Receptor key companies, revenue, market share, and recent developments.

3. To split the G-protein Coupled Receptor breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions G-protein Coupled Receptor market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify G-protein Coupled Receptor significant trends, drivers, influence factors in global and regions.

6. To analyze G-protein Coupled Receptor competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global G-protein Coupled Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of G-protein Coupled Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of G-protein Coupled Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global G-protein Coupled Receptor industry.

Chapter 3: Detailed analysis of G-protein Coupled Receptor company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of G-protein Coupled Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of G-protein Coupled Receptor in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. G-protein Coupled Receptor Industry Trends Table 2. G-protein Coupled Receptor Industry Drivers Table 3. G-protein Coupled Receptor Industry Opportunities and Challenges Table 4. G-protein Coupled Receptor Industry Restraints Table 5. Global G-protein Coupled Receptor Revenue by Company (US$ Million) & (2021-2026) Table 6. Global G-protein Coupled Receptor Revenue Share by Company (2021-2026) Table 7. Global G-protein Coupled Receptor Company Ranking, (2024-2026) & (US$ Million) Table 8. Global G-protein Coupled Receptor Key Company Manufacturing Base & Headquarters Table 9. Global G-protein Coupled Receptor Company, Product Type & Application Table 10. Global G-protein Coupled Receptor Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global G-protein Coupled Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of cAMP Assays Table 15. Significant Companies of cGMP Assays Table 16. Significant Companies of GTPγS Binding Assays Table 17. Significant Companies of Reporter Gene Assays Table 18. Significant Companies of Calcium Level Detection Assays Table 19. Significant Companies of Receptor Internalization Assays Table 20. Global G-protein Coupled Receptor Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global G-protein Coupled Receptor Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global G-protein Coupled Receptor Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global G-protein Coupled Receptor Sales Value Share by Type (2021-2026) Table 24. Global G-protein Coupled Receptor Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Oncology Table 26. Significant Companies of Central Nervous System Table 27. Significant Companies of Cardiovascular System Table 28. Significant Companies of Reproductive System Table 29. Significant Companies of Immune System Table 30. Significant Companies of Respiratory System Table 31. Significant Companies of Others Table 32. Global G-protein Coupled Receptor Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global G-protein Coupled Receptor Sales Value by Application (2021-2026) & (US$ Million) Table 34. Global G-protein Coupled Receptor Sales Value by Application (2027-2032) & (US$ Million) Table 35. Global G-protein Coupled Receptor Sales Value Share by Application (2021-2026) Table 36. Global G-protein Coupled Receptor Sales Value Share by Application (2027-2032) Table 37. Global G-protein Coupled Receptor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global G-protein Coupled Receptor Sales Value by Region (2021-2026) & (US$ Million) Table 39. Global G-protein Coupled Receptor Sales Value Share by Region (2021-2026) Table 40. Global G-protein Coupled Receptor Sales Value by Region (2027-2032) & (US$ Million) Table 41. Global G-protein Coupled Receptor Sales Value Share by Region (2027-2032) Table 42. Global G-protein Coupled Receptor Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global G-protein Coupled Receptor Sales Value by Country (2021-2026) & (US$ Million) Table 44. Global G-protein Coupled Receptor Sales Value Market Share by Country (2021-2026) Table 45. Global G-protein Coupled Receptor Sales Value by Country (2027-2032) & (US$ Million) Table 46. Global G-protein Coupled Receptor Sales Value Market Share by Country (2027-2032) Table 47. Abcam plc Company Information Table 48. Abcam plc Business Overview Table 49. Abcam plc G-protein Coupled Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Abcam plc G-protein Coupled Receptor Product Portfolio Table 51. Abcam plc Recent Development Table 52. Becton, Dickinson Company Information Table 53. Becton, Dickinson Business Overview Table 54. Becton, Dickinson G-protein Coupled Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Becton, Dickinson G-protein Coupled Receptor Product Portfolio Table 56. Becton, Dickinson Recent Development Table 57. Cisbio Bioassays Company Information Table 58. Cisbio Bioassays Business Overview Table 59. Cisbio Bioassays G-protein Coupled Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Cisbio Bioassays G-protein Coupled Receptor Product Portfolio Table 61. Cisbio Bioassays Recent Development Table 62. DiscoveRx Corporation Company Information Table 63. DiscoveRx Corporation Business Overview Table 64. DiscoveRx Corporation G-protein Coupled Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. DiscoveRx Corporation G-protein Coupled Receptor Product Portfolio Table 66. DiscoveRx Corporation Recent Development Table 67. EMD Millipore Company Information Table 68. EMD Millipore Business Overview Table 69. EMD Millipore G-protein Coupled Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. EMD Millipore G-protein Coupled Receptor Product Portfolio Table 71. EMD Millipore Recent Development Table 72. Enzo Life Sciences, Inc. Company Information Table 73. Enzo Life Sciences, Inc. Business Overview Table 74. Enzo Life Sciences, Inc. G-protein Coupled Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Enzo Life Sciences, Inc. G-protein Coupled Receptor Product Portfolio Table 76. Enzo Life Sciences, Inc. Recent Development Table 77. HD Biosciences Co. Ltd. Company Information Table 78. HD Biosciences Co. Ltd. Business Overview Table 79. HD Biosciences Co. Ltd. G-protein Coupled Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. HD Biosciences Co. Ltd. G-protein Coupled Receptor Product Portfolio Table 81. HD Biosciences Co. Ltd. Recent Development Table 82. PerkinElmer, Inc. Company Information Table 83. PerkinElmer, Inc. Business Overview Table 84. PerkinElmer, Inc. G-protein Coupled Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. PerkinElmer, Inc. G-protein Coupled Receptor Product Portfolio Table 86. PerkinElmer, Inc. Recent Development Table 87. Promega Corporation Company Information Table 88. Promega Corporation Business Overview Table 89. Promega Corporation G-protein Coupled Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Promega Corporation G-protein Coupled Receptor Product Portfolio Table 91. Promega Corporation Recent Development Table 92. Qiagen Company Information Table 93. Qiagen Business Overview Table 94. Qiagen G-protein Coupled Receptor Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Qiagen G-protein Coupled Receptor Product Portfolio Table 96. Qiagen Recent Development Table 97. AbbVie Company Information Table 98. AbbVie Business Overview Table 99. AbbVie G-protein Coupled Receptor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. AbbVie G-protein Coupled Receptor Product Portfolio Table 101. AbbVie Recent Development Table 102. Thermo Fisher Scientific, Inc. Company Information Table 103. Thermo Fisher Scientific, Inc. Business Overview Table 104. Thermo Fisher Scientific, Inc. G-protein Coupled Receptor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Thermo Fisher Scientific, Inc. G-protein Coupled Receptor Product Portfolio Table 106. Thermo Fisher Scientific, Inc. Recent Development Table 107. Abbott Company Information Table 108. Abbott Business Overview Table 109. Abbott G-protein Coupled Receptor Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Abbott G-protein Coupled Receptor Product Portfolio Table 111. Abbott Recent Development Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. G-protein Coupled Receptor Product Image Figure 2. Global G-protein Coupled Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global G-protein Coupled Receptor Market Size (2021-2032) & (US$ Million) Figure 4. Global G-protein Coupled Receptor Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. cAMP Assays Image Figure 8. cGMP Assays Image Figure 9. GTPγS Binding Assays Image Figure 10. Reporter Gene Assays Image Figure 11. Calcium Level Detection Assays Image Figure 12. Receptor Internalization Assays Image Figure 13. Global G-protein Coupled Receptor Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global G-protein Coupled Receptor Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global G-protein Coupled Receptor Sales Value Share by Type (2021-2032) Figure 16. Oncology Image Figure 17. Central Nervous System Image Figure 18. Cardiovascular System Image Figure 19. Reproductive System Image Figure 20. Immune System Image Figure 21. Respiratory System Image Figure 22. Others Image Figure 23. Global G-protein Coupled Receptor Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global G-protein Coupled Receptor Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global G-protein Coupled Receptor Sales Value Share by Application (2021-2032) Figure 26. Global G-protein Coupled Receptor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 27. Global G-protein Coupled Receptor Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 28. North America G-protein Coupled Receptor Sales Value (2021-2032) & (US$ Million) Figure 29. North America G-protein Coupled Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Europe G-protein Coupled Receptor Sales Value (2021-2032) & (US$ Million) Figure 31. Europe G-protein Coupled Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Asia-Pacific G-protein Coupled Receptor Sales Value (2021-2032) & (US$ Million) Figure 33. Asia-Pacific G-protein Coupled Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 34. South America G-protein Coupled Receptor Sales Value (2021-2032) & (US$ Million) Figure 35. South America G-protein Coupled Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Middle East & Africa G-protein Coupled Receptor Sales Value (2021-2032) & (US$ Million) Figure 37. Middle East & Africa G-protein Coupled Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 38. USA G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. USA G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. USA G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Canada G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Canada G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Canada G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Mexico G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Mexico G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Mexico G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Germany G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Germany G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Germany G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. France G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. France G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. France G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. U.K. G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. U.K. G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. U.K. G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Italy G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Italy G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Italy G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Spain G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Spain G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Spain G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Russia G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Russia G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Russia G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Netherlands G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Netherlands G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Netherlands G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Nordic Countries G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Nordic Countries G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Nordic Countries G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. China G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. China G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. China G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Japan G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Japan G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Japan G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. South Korea G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. South Korea G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. South Korea G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. India G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. India G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. India G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Australia G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Australia G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Australia G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Southeast Asia G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Southeast Asia G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Southeast Asia G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Brazil G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Brazil G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Brazil G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Argentina G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Argentina G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Argentina G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Chile G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Chile G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Chile G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Colombia G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Colombia G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Colombia G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Peru G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Peru G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Peru G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Saudi Arabia G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Saudi Arabia G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Saudi Arabia G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Israel G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Israel G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Israel G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. UAE G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. UAE G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. UAE G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Turkey G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Turkey G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Turkey G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Iran G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Iran G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Iran G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Egypt G-protein Coupled Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Egypt G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Egypt G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Years Considered Figure 123. Research Process Figure 124. Key Executives Interviewed

Scope & coverage.

Types
  • cAMP Assays
  • cGMP Assays
  • GTPγS Binding Assays
  • Reporter Gene Assays
  • Calcium Level Detection Assays
  • Receptor Internalization Assays
Applications
  • Oncology
  • Central Nervous System
  • Cardiovascular System
  • Reproductive System
  • Immune System
  • Respiratory System
  • Others
Companies covered
  • Abcam plc
  • Becton, Dickinson
  • Cisbio Bioassays
  • DiscoveRx Corporation
  • EMD Millipore
  • Enzo Life Sciences, Inc.
  • HD Biosciences Co. Ltd.
  • PerkinElmer, Inc.
  • Promega Corporation
  • Qiagen
  • AbbVie
  • Thermo Fisher Scientific, Inc.
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global G-protein Coupled Receptor Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global G-protein Coupled Receptor Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 G-protein Coupled Receptor Market Dynamics
  1. 2.1 G-protein Coupled Receptor Industry Trends
  2. 2.2 G-protein Coupled Receptor Industry Drivers
  3. 2.3 G-protein Coupled Receptor Industry Opportunities and Challenges
  4. 2.4 G-protein Coupled Receptor Industry Restraints
3 G-protein Coupled Receptor Market by Company
  1. 3.1 Global G-protein Coupled Receptor Company Revenue Ranking in 2025
  2. 3.2 Global G-protein Coupled Receptor Revenue by Company (2021-2026)
  3. 3.3 Global G-protein Coupled Receptor Company Ranking (2024-2026)
  4. 3.4 Global G-protein Coupled Receptor Company Manufacturing Base and Headquarters
  5. 3.5 Global G-protein Coupled Receptor Company Product Type and Application
  6. 3.6 Global G-protein Coupled Receptor Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global G-protein Coupled Receptor Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 G-protein Coupled Receptor Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 G-protein Coupled Receptor Market by Type
  1. 4.1 G-protein Coupled Receptor Type Introduction
  2. 4.1.1 cAMP Assays
  3. 4.1.2 cGMP Assays
  4. 4.1.3 GTPγS Binding Assays
  5. 4.1.4 Reporter Gene Assays
  6. 4.1.5 Calcium Level Detection Assays
  7. 4.1.6 Receptor Internalization Assays
  8. 4.2 Global G-protein Coupled Receptor Sales Value by Type
  9. 4.2.1 Global G-protein Coupled Receptor Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global G-protein Coupled Receptor Sales Value by Type (2021-2032)
  11. 4.2.3 Global G-protein Coupled Receptor Sales Value Share by Type (2021-2032)
5 G-protein Coupled Receptor Market by Application
  1. 5.1 G-protein Coupled Receptor Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Central Nervous System
  4. 5.1.3 Cardiovascular System
  5. 5.1.4 Reproductive System
  6. 5.1.5 Immune System
  7. 5.1.6 Respiratory System
  8. 5.1.7 Others
  9. 5.2 Global G-protein Coupled Receptor Sales Value by Application
  10. 5.2.1 Global G-protein Coupled Receptor Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.2.2 Global G-protein Coupled Receptor Sales Value by Application (2021-2032)
  12. 5.2.3 Global G-protein Coupled Receptor Sales Value Share by Application (2021-2032)
6 G-protein Coupled Receptor Regional Value Analysis
  1. 6.1 Global G-protein Coupled Receptor Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global G-protein Coupled Receptor Sales Value by Region (2021-2032)
  3. 6.2.1 Global G-protein Coupled Receptor Sales Value by Region: 2021-2026
  4. 6.2.2 Global G-protein Coupled Receptor Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America G-protein Coupled Receptor Sales Value (2021-2032)
  7. 6.3.2 North America G-protein Coupled Receptor Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe G-protein Coupled Receptor Sales Value (2021-2032)
  10. 6.4.2 Europe G-protein Coupled Receptor Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific G-protein Coupled Receptor Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific G-protein Coupled Receptor Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America G-protein Coupled Receptor Sales Value (2021-2032)
  16. 6.6.2 South America G-protein Coupled Receptor Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa G-protein Coupled Receptor Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa G-protein Coupled Receptor Sales Value Share by Country, 2025 VS 2032
7 G-protein Coupled Receptor Country-level Value Analysis
  1. 7.1 Global G-protein Coupled Receptor Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global G-protein Coupled Receptor Sales Value by Country (2021-2032)
  3. 7.2.1 Global G-protein Coupled Receptor Sales Value by Country (2021-2026)
  4. 7.2.2 Global G-protein Coupled Receptor Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt G-protein Coupled Receptor Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt G-protein Coupled Receptor Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt G-protein Coupled Receptor Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abcam plc
  2. 8.1.1 Abcam plc Company Information
  3. 8.1.2 Abcam plc Business Overview
  4. 8.1.3 Abcam plc G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abcam plc G-protein Coupled Receptor Product Portfolio
  6. 8.1.5 Abcam plc Recent Developments
  7. 8.2 Becton, Dickinson
  8. 8.2.1 Becton, Dickinson Company Information
  9. 8.2.2 Becton, Dickinson Business Overview
  10. 8.2.3 Becton, Dickinson G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Becton, Dickinson G-protein Coupled Receptor Product Portfolio
  12. 8.2.5 Becton, Dickinson Recent Developments
  13. 8.3 Cisbio Bioassays
  14. 8.3.1 Cisbio Bioassays Company Information
  15. 8.3.2 Cisbio Bioassays Business Overview
  16. 8.3.3 Cisbio Bioassays G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cisbio Bioassays G-protein Coupled Receptor Product Portfolio
  18. 8.3.5 Cisbio Bioassays Recent Developments
  19. 8.4 DiscoveRx Corporation
  20. 8.4.1 DiscoveRx Corporation Company Information
  21. 8.4.2 DiscoveRx Corporation Business Overview
  22. 8.4.3 DiscoveRx Corporation G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  23. 8.4.4 DiscoveRx Corporation G-protein Coupled Receptor Product Portfolio
  24. 8.4.5 DiscoveRx Corporation Recent Developments
  25. 8.5 EMD Millipore
  26. 8.5.1 EMD Millipore Company Information
  27. 8.5.2 EMD Millipore Business Overview
  28. 8.5.3 EMD Millipore G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  29. 8.5.4 EMD Millipore G-protein Coupled Receptor Product Portfolio
  30. 8.5.5 EMD Millipore Recent Developments
  31. 8.6 Enzo Life Sciences, Inc.
  32. 8.6.1 Enzo Life Sciences, Inc. Company Information
  33. 8.6.2 Enzo Life Sciences, Inc. Business Overview
  34. 8.6.3 Enzo Life Sciences, Inc. G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Enzo Life Sciences, Inc. G-protein Coupled Receptor Product Portfolio
  36. 8.6.5 Enzo Life Sciences, Inc. Recent Developments
  37. 8.7 HD Biosciences Co. Ltd.
  38. 8.7.1 HD Biosciences Co. Ltd. Company Information
  39. 8.7.2 HD Biosciences Co. Ltd. Business Overview
  40. 8.7.3 HD Biosciences Co. Ltd. G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  41. 8.7.4 HD Biosciences Co. Ltd. G-protein Coupled Receptor Product Portfolio
  42. 8.7.5 HD Biosciences Co. Ltd. Recent Developments
  43. 8.8 PerkinElmer, Inc.
  44. 8.8.1 PerkinElmer, Inc. Company Information
  45. 8.8.2 PerkinElmer, Inc. Business Overview
  46. 8.8.3 PerkinElmer, Inc. G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  47. 8.8.4 PerkinElmer, Inc. G-protein Coupled Receptor Product Portfolio
  48. 8.8.5 PerkinElmer, Inc. Recent Developments
  49. 8.9 Promega Corporation
  50. 8.9.1 Promega Corporation Company Information
  51. 8.9.2 Promega Corporation Business Overview
  52. 8.9.3 Promega Corporation G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Promega Corporation G-protein Coupled Receptor Product Portfolio
  54. 8.9.5 Promega Corporation Recent Developments
  55. 8.10 Qiagen
  56. 8.10.1 Qiagen Company Information
  57. 8.10.2 Qiagen Business Overview
  58. 8.10.3 Qiagen G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Qiagen G-protein Coupled Receptor Product Portfolio
  60. 8.10.5 Qiagen Recent Developments
  61. 8.11 AbbVie
  62. 8.11.1 AbbVie Company Information
  63. 8.11.2 AbbVie Business Overview
  64. 8.11.3 AbbVie G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  65. 8.11.4 AbbVie G-protein Coupled Receptor Product Portfolio
  66. 8.11.5 AbbVie Recent Developments
  67. 8.12 Thermo Fisher Scientific, Inc.
  68. 8.12.1 Thermo Fisher Scientific, Inc. Company Information
  69. 8.12.2 Thermo Fisher Scientific, Inc. Business Overview
  70. 8.12.3 Thermo Fisher Scientific, Inc. G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Thermo Fisher Scientific, Inc. G-protein Coupled Receptor Product Portfolio
  72. 8.12.5 Thermo Fisher Scientific, Inc. Recent Developments
  73. 8.13 Abbott
  74. 8.13.1 Abbott Company Information
  75. 8.13.2 Abbott Business Overview
  76. 8.13.3 Abbott G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Abbott G-protein Coupled Receptor Product Portfolio
  78. 8.13.5 Abbott Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst